The Ocular Safety, Tolerability, and Efficacy of Once Daily and Twice Daily 0.075% Bromfenac Ophthalmic Solution (Formulated in DuraSite (R)) in Patients Post Cataract Surgery

Shafiee Afshin; Hutcheson Judith; Bowman Lyle; Hosseini Kamran

首页> 外文期刊>Investigative ophthalmology & visual science >The Ocular Safety, Tolerability, and Efficacy of Once Daily and Twice Daily 0.075% Bromfenac Ophthalmic Solution (Formulated in DuraSite (R)) in Patients Post Cataract Surgery

【24h】

The Ocular Safety, Tolerability, and Efficacy of Once Daily and Twice Daily 0.075% Bromfenac Ophthalmic Solution (Formulated in DuraSite (R)) in Patients Post Cataract Surgery

机译：每日一次和每日一次的眼部安全性，耐受性和功效0.075％溴芬卡克眼科溶液（在白内障手术后患者的患者中制定在DuRasite（R）中）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Investigative ophthalmology & visual science》 |2017年第8期|共2页
作者
Shafiee Afshin; Hutcheson Judith; Bowman Lyle; Hosseini Kamran;
展开▼
作者单位

InSite Vis Preclin Res &

Dev Alameda CA USA;

InSite Vis Clin Alameda CA USA;

InSite Vis Dev Alameda CA USA;

InSite Vis Clin Alameda CA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. The Ocular Safety, Tolerability, and Efficacy of Once Daily and Twice Daily 0.075% Bromfenac Ophthalmic Solution (Formulated in DuraSite (R)) in Patients Post Cataract Surgery [J] . Shafiee Afshin, Hutcheson Judith, Bowman Lyle, Investigative ophthalmology & visual science . 2017,第8期

机译：每日一次和每日一次的眼部安全性，耐受性和功效0.075％溴芬卡克眼科溶液（在白内障手术后患者的患者中制定在DuRasite（R）中）
2. Efficacy and safety of bromfenac 0.075% formulated in DuraSite for pain and inflammation in cataract surgery [J] . Wentz Scott M., Price Francis, Harris Alon, Expert opinion on pharmacotherapy . 2019,第13a18期

机译：Bromfenac 0.075％在白内障手术中粘疼痛和炎症的菌株和安全性的疗效和安全性
3. A randomized double-masked study to compare the ocular safety, tolerability, and efficacy of bromfenac 0.075% compared with vehicle in cataract surgery subjects [J] . Kamran Hosseini, Thomas Walters, Robert DaVanzo, Clinical ophthalmology . 2016,第2期

机译：在白内障手术对象中进行随机双盲研究，比较溴芬酸与赋形剂相比，眼用安全性，耐受性和功效为0.075％
4. Ocular safety limits for 1030 nm femtosecond laser cataract surgery [C] . Jenny Wang, Christopher Sramek, Yannis M. Paulus, Ophthalmic technology XXIII . 2013

机译：1030 nm飞秒激光白内障手术的眼部安全极限
5. Healthy Work Environments: Skilled Communication in Daily Patient Safety Briefings Impacts Fall Prevention [D] . Bradshaw, Debra Cabell. 2021

机译：健康的工作环境：每日患者安全简报中的熟练沟通影响降临预防
6. A randomized double-masked study to compare the ocular safety tolerability and efficacy of bromfenac 0.075 compared with vehicle in cataract surgery subjects [O] . Kamran Hosseini, Thomas Walters, Robert DaVanzo, 2016

机译：在白内障手术对象中进行随机双盲研究以比较溴芬酸与赋形剂相比眼用安全性耐受性和功效为0.075％
7. The efficacy of bromfenac ophthalmic solution 0.07 dosed once daily in achieving zero-to-trace anterior chamber cell severity following cataract surgery [O] . Steven M. Silverstein MD FACS, Damien Goldberg, Mauricio Munoz, 2014

机译：Bromfenac眼科溶液的功效每日0.07％，在白内障手术后实现零对痕量室细胞严重程度

The Ocular Safety, Tolerability, and Efficacy of Once Daily and Twice Daily 0.075% Bromfenac Ophthalmic Solution (Formulated in DuraSite (R)) in Patients Post Cataract Surgery

著录项

相似文献

相关主题

期刊订阅